BioNTech SE 22UA-DE:XETRA

*Data is delayed | EUR
Last | 12/03/21 CET
295.60quote price arrow up+11.20 (+3.94%)
Volume
380,059
52 week range
65.50 - 395.00
Loading...
  • Open297.90
  • Day High306.50
  • Day Low289.50
  • Prev Close284.40
  • 52 Week High395.00
  • 52 Week High Date08/10/21
  • 52 Week Low65.50
  • 52 Week Low Date12/29/20

Key Stats

  • Market Cap83,097.74M
  • Shares Out241.52M
  • 10 Day Average Volume655,056.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change305.04

KEY STATS

  • Open297.90
  • Day High306.50
  • Day Low289.50
  • Prev Close284.40
  • 52 Week High395.00
  • 52 Week High Date08/10/21
  • 52 Week Low65.50
  • 52 Week Low Date12/29/20
  • Market Cap83,097.74M
  • Shares Out241.52M
  • 10 Day Average Volume655,056.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change305.04

RATIOS/PROFITABILITY

  • EPS (TTM)29.58
  • P/E (TTM)9.99
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO3:0603:06
What worked today: PFE up even as MRNA sinks

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany